FanDuel and DraftKings Ban Credit Cards, Reshaping U.S. Sports Betting Payments
Industry leaders controlling over 70% of the market shift toward debit and cash-based deposits amid regulatory pressure The U.S. online ...
Tag: Movers
FDA Approves Novocure’s Optune Pax®, Marking Major Breakthrough in Pancreatic Cancer Treatment
First new therapy in nearly 30 years delivers survival benefit using innovative electric field technology The U.S. Food and Drug ...
Viking Therapeutics Moves Oral Obesity Drug Into Late-Stage Development
Company advances VKTX program as competition intensifies in the rapidly expanding weight-loss market Viking Therapeutics (VKTX) announced Wednesday that it ...
Banks Push Back on Stablecoin Yields, Freezing Key Crypto Bill in Congress
Clash over interest payments pits Wall Street against digital asset firms as Clarity Act stalls A growing showdown between major ...
FDA Flags Novo Nordisk’s Wegovy Pill Ad for Misleading Claims
Regulatory scrutiny adds pressure as competition intensifies in the booming GLP-1 market Food and Drug Administration has issued a warning ...
Oracle Rebounds as Big Tech’s AI Spending Revives Software Optimism
Massive cloud capex plans ease fears that AI will sideline enterprise software Oracle Corp. (ORCL) shares surged Monday, extending a ...
Hims & Hers Shares Plunge as FDA Tightens Grip on Compounded GLP-1 Drugs
Regulatory crackdown and Novo Nordisk lawsuit rattle investors and reshape weight-loss drug landscape Shares of Hims & Hers Health (HIMS) ...
Stellantis Takes $26 Billion EV Write-Down as Electrification Strategy Resets
Automaker posts 2025 net loss after acknowledging missteps in the pace of the energy transition Stellantis shocked markets after announcing ...
Dentsply Sirona’s $45 Bull Case: A Turnaround Leveraged to a Dental Recovery
If demand stabilizes, cost savings stick, and digital/aligners re-accelerate, XRAY could re-rate sharply Dentsply Sirona (XRAY) has been treated like ...
Amazon Beats Earnings, but Massive AI Spending Spooks Investors
Strong AWS growth fails to offset softer guidance and a sharp jump in capital expenditures Amazon (AMZN) delivered a solid ...
